4//SEC Filing
Anacor Pharmaceuticals, Inc. 4
Accession 0001209191-15-010082
CIK 0001411158operating
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 8:51 PM ET
Size
10.8 KB
Accession
0001209191-15-010082
Insider Transaction Report
Form 4
Chanda Sanjay
VP & Interim Head of Drug Deve
Transactions
- Award
Performance Restricted Stock Units
2015-02-03+1,475→ 1,475 total→ Common Stock (1,475 underlying) - Award
Stock Option (right to buy)
2015-02-03+20,845→ 20,845 totalExercise: $37.81Exp: 2025-02-03→ Common Stock (20,845 underlying) - Award
Common Stock
2015-02-03+5,020→ 29,087 total
Footnotes (4)
- [F1]Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2015.
- [F2]Includes 999 shares purchased on January 30, 2015 pursuant to Issuer's ESPP.
- [F3]The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting each month thereafter. The Vesting Commencement Date is January 1, 2015.
- [F4]Represents performance restricted stock units granted to the Reporting Person. Each performance restricted stock unit represents a contingent right to receive one share of Issuer's Common Stock. In the event that the volume-weighted average price of the Issuer's common stock equals or exceeds (i) $80.00 per share for 30 consecutive trading days prior to the first anniversary of the Vesting Commencement Date or (ii) $100.00 per share for 30 consecutive trading days prior to the second anniversary of the Vesting Commencement Date, the shares subject to the award shall vest in two equal annual installments following the date on which the condition specified in clause (i) or (ii) is met. The Vesting Commencement Date is January 1, 2015.
Documents
Issuer
Anacor Pharmaceuticals, Inc.
CIK 0001411158
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411158
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 8:51 PM ET
- Size
- 10.8 KB